E-LIB Suche - Ergebnisse für: Bertelsen, K.

1

Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibit..:

Barchuk, W. ; Lambert, J. ; Fuhr, R....
Pulmonary Pharmacology & Therapeutics. 29 (2014) 1 - p. 15-23 , 2014

Link: https://doi.org/10.1016/..

2

P1209 FACTORS INFLUENCING RENAL FUNCTION IN PATIENTS RECEIV..:

Buti, M. ; Agarwal, K. ; Horsmans, Y....
Journal of Hepatology. 60 (2014) 1 - p. S491 , 2014

Link: https://doi.org/10.1016/..

3

P1186 TREATMENT-NAIVE STABLE LIVER TRANSPLANT PATIENTS WITH..:

Forns, X. ; Samuel, D. ; Mutimer, D....
Journal of Hepatology. 60 (2014) 1 - p. S481-S482 , 2014

Link: https://doi.org/10.1016/..

4

Small fibre neuropathy in Fabry disease:

Bertelsen, A. K. ; Tøndel, C. ; Krohn, J....
Journal of Neurology. 260 (2012) 3 - p. 917-919 , 2012

Link: https://doi.org/10.1007/..

5

Conceptual and user-centric design guidelines for a plant n..:

Sørensen, C.G. ; Jørgensen, R.N. ; Maagaard, J....
Biosystems Engineering. 105 (2010) 1 - p. 119-129 , 2010

Link: https://doi.org/10.1016/..

6

Vascular Effects of RWJ-676070, a Selective Combined V1a/V2..:

Coltamai, L ; Bucher, M ; Maillard, MP...
Clinical Pharmacology & Therapeutics. 85 (2008) 2 - p. 145-148 , 2008

Link: https://doi.org/10.1038/..

7

Stimulation of P-GP mediated transport & expression by flut..:

BERTELSEN, K ; VONMOLTKE, L ; GREENBLATT, D
Clinical Pharmacology & Therapeutics. 77 (2005) 2 - p. P42-P42 , 2005

Link: https://doi.org/10.1016/..

8

Differential modulation of CACO-2 mediated transport of rho..:

Bertelsen, K
Clinical Pharmacology & Therapeutics. 75 (2004) 2 - p. P87 , 2004

Link: https://doi.org/10.1016/..

9

40 Prognostic significance of P53, EGFR and Her-2 expressio..:

Stab Nielsen, J. ; Jakobsen, E. ; Hoelund, B...
European Journal of Cancer Supplements. 1 (2003) 5 - p. S16 , 2003

Link: https://doi.org/10.1016/..

10

Long-lived states ofN2−:Formation, lifetimes, and identity:

Andersen, T. ; Bertelsen, K. A. ; Raarup, M. K....
Physical Review A. 60 (1999) 5 - p. 3627-3632 , 1999

Link: https://doi.org/10.1103/..

11

Is cisplatin-taxol (PT) the standard treatment in advanced ..:

Bertelsen, K. ; Kaem, J. ; Simonsen, E....
European Journal of Cancer. 33 (1997) - p. S138 , 1997

Link: https://doi.org/10.1016/..

12

489 A dose intensity study of carboplatin in ovarian cancer:

Bertelsen, K.
European Journal of Cancer. 31 (1995) - p. S104-S105 , 1995

Link: https://doi.org/10.1016/..

13

A Phase 2 Trial of Ifosfamide/Mesna as Salvage Therapy in P..:

Sørensen, P. ; Pfeiffer, P. ; Bertelsen, K.
Gynecologic Oncology. 56 (1995) 1 - p. 75-78 , 1995

Link: https://doi.org/10.1006/..

14

A Prospective Randomized Comparison of 6 and 12 Cycles of C..:

Bertelsen, K. ; Jakobsen, A. ; Strøyer, I....
Gynecologic Oncology. 49 (1993) 1 - p. 30-36 , 1993

Link: https://doi.org/10.1006/..

15

Tumor reduction surgery and long‐term survival in advanced ..:

Bertelsen, K
International Journal of Gynecology & Obstetrics. 35 (1991) 1 - p. 96-97 , 1991

Link: https://doi.org/10.1016/..